Douglas Murray is the chief executive officer at Auvik.

The best endpoint protection software provides an easy way to manage all of the devices within your business IT network, and keep them protected from malware and cyber attacks. To best protect a ...

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

The latest VIPRE Endpoint EDR+MDR package empowers businesses with continuous expert incident response and a robust security ...

Syndax Pharmaceuticals has announced that its Phase II trial of revumenib achieved its primary endpoint in certain patients ...

Ivanti is patching numerous security vulnerabilities in various products, some of which are critical. IT managers should take ...

“What’s new with the launch of FortiDLP is that this is our first, standalone endpoint DLP solution, and is part of a broader strategy to expand and enhance our overall data protection portfolio,” ...

The SELECT-MDS-1 trial showed no significant complete response rate improvement with tamibarotene plus azacitidine for ...

Syros Pharmaceuticals announced that its phase 3 trial of tamibarotene in combination with azacitidine did not meet the primary endpoint for the treatment of myelodysplastic syndrome.

AbbVie (NYSE:ABBV) has announced that its two phase 2 trials of a treatment for adults with schizophrenia missed its primary endpoint, sending shares in the drugmaker down sharply in premarket US ...